222 related articles for article (PubMed ID: 23359816)
21. Failure to detect hypnozoites in hepatic tissue containing exoerythrocytic schizonts of Plasmodium knowlesi.
Krotoski WA; Collins WE
Am J Trop Med Hyg; 1982 Jul; 31(4):854-6. PubMed ID: 7048949
[TBL] [Abstract][Full Text] [Related]
22. Dual-Luciferase-Based Fast and Sensitive Detection of Malaria Hypnozoites for the Discovery of Anti-relapse Compounds.
Voorberg-van der Wel AM; Zeeman AM; Nieuwenhuis IG; van der Werff NM; Kocken CHM
Methods Mol Biol; 2022; 2524():397-408. PubMed ID: 35821489
[TBL] [Abstract][Full Text] [Related]
23. Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
Adekunle AI; Pinkevych M; McGready R; Luxemburger C; White LJ; Nosten F; Cromer D; Davenport MP
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003595. PubMed ID: 25780913
[TBL] [Abstract][Full Text] [Related]
24. Development of an effective alternative model for in vivo hypnozoite-induced relapse infection: A Japanese macaque (Macaca fuscata) model experimentally infected with Plasmodium cynomolgi.
Kawai S; Annoura T; Araki T; Shiogama Y; Soma S; Takano JI; Sato MO; Kaneko O; Yasutomi Y; Chigusa Y
Parasitol Int; 2020 Jun; 76():102096. PubMed ID: 32114084
[TBL] [Abstract][Full Text] [Related]
25. Epigenetically regulated RNA-binding proteins signify malaria hypnozoite dormancy.
Toenhake CG; Voorberg-van der Wel A; Wu H; Kanyal A; Nieuwenhuis IG; van der Werff NM; Hofman SO; Zeeman AM; Kocken CHM; Bártfai R
Cell Rep; 2023 Jul; 42(7):112727. PubMed ID: 37392389
[TBL] [Abstract][Full Text] [Related]
26. Transfection Models to Investigate
Voorberg-van der Wel A; Zeeman AM; Kocken CHM
Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764878
[No Abstract] [Full Text] [Related]
27.
Flannery EL; Kangwanrangsan N; Chuenchob V; Roobsoong W; Fishbaugher M; Zhou K; Billman ZP; Martinson T; Olsen TM; Schäfer C; Campo B; Murphy SC; Mikolajczak SA; Kappe SHI; Sattabongkot J
Mol Ther Methods Clin Dev; 2022 Sep; 26():427-440. PubMed ID: 36092359
[No Abstract] [Full Text] [Related]
28.
Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
[No Abstract] [Full Text] [Related]
29. A model of Plasmodium vivax concealment based on Plasmodium cynomolgi infections in Macaca mulatta.
Fonseca LL; Joyner CJ; ; Galinski MR; Voit EO
Malar J; 2017 Sep; 16(1):375. PubMed ID: 28923058
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine Potentiates Primaquine Activity against Active and Latent Hepatic Plasmodia
Dembélé L; Franetich JF; Soulard V; Amanzougaghene N; Tajeri S; Bousema T; van Gemert GJ; Le Grand R; Dereuddre-Bosquet N; Baird JK; Mazier D; Snounou G
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077656
[TBL] [Abstract][Full Text] [Related]
31. Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures.
Dembélé L; Franetich JF; Lorthiois A; Gego A; Zeeman AM; Kocken CH; Le Grand R; Dereuddre-Bosquet N; van Gemert GJ; Sauerwein R; Vaillant JC; Hannoun L; Fuchter MJ; Diagana TT; Malmquist NA; Scherf A; Snounou G; Mazier D
Nat Med; 2014 Mar; 20(3):307-12. PubMed ID: 24509527
[TBL] [Abstract][Full Text] [Related]
32. Tissue schizontocidal effect of trifluoroacetyl primaquine in Plasmodium yoelii infected mice and Plasmodium cynomolgi infected monkeys.
Shao BR; Ye XY
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):81-3. PubMed ID: 1948265
[TBL] [Abstract][Full Text] [Related]
33. Hepatic spheroids used as an in vitro model to study malaria relapse.
Chua ACY; Ananthanarayanan A; Ong JJY; Wong JY; Yip A; Singh NH; Qu Y; Dembele L; McMillian M; Ubalee R; Davidson S; Tungtaeng A; Imerbsin R; Gupta K; Andolina C; Lee F; S-W Tan K; Nosten F; Russell B; Lange A; Diagana TT; Rénia L; Yeung BKS; Yu H; Bifani P
Biomaterials; 2019 Sep; 216():119221. PubMed ID: 31195301
[TBL] [Abstract][Full Text] [Related]
34. Observations on early and late post-sporozoite tissue stages in primate malaria. I. Discovery of a new latent form of Plasmodium cynomolgi (the hypnozoite), and failure to detect hepatic forms within the first 24 hours after infection.
Krotoski WA; Garnham PC; Bray RS; Krotoski DM; Killick-Kendrick R; Draper CC; Targett GA; Guy MW
Am J Trop Med Hyg; 1982 Jan; 31(1):24-35. PubMed ID: 7058977
[TBL] [Abstract][Full Text] [Related]
35. A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages.
Schafer C; Dambrauskas N; Steel RW; Carbonetti S; Chuenchob V; Flannery EL; Vigdorovich V; Oliver BG; Roobsoong W; Maher SP; Kyle D; Sattabongkot J; Kappe SHI; Mikolajczak SA; Sather DN
Malar J; 2018 Oct; 17(1):370. PubMed ID: 30333026
[TBL] [Abstract][Full Text] [Related]
36. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.
Chattopadhyay R; Velmurugan S; Chakiath C; Andrews Donkor L; Milhous W; Barnwell JW; Collins WE; Hoffman SL
PLoS One; 2010 Dec; 5(12):e14275. PubMed ID: 21151554
[TBL] [Abstract][Full Text] [Related]
37. A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax.
Pewkliang Y; Rungin S; Lerdpanyangam K; Duangmanee A; Kanjanasirirat P; Suthivanich P; Sa-Ngiamsuntorn K; Borwornpinyo S; Sattabongkot J; Patrapuvich R; Hongeng S
Malar J; 2018 Jan; 17(1):50. PubMed ID: 29370800
[TBL] [Abstract][Full Text] [Related]
38. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
Wells TN; Burrows JN; Baird JK
Trends Parasitol; 2010 Mar; 26(3):145-51. PubMed ID: 20133198
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents.
Azad CS; Saxena M; Siddiqui AJ; Bhardwaj J; Puri SK; Dutta GP; Anand N; Saxena AK
Chem Biol Drug Des; 2017 Aug; 90(2):254-261. PubMed ID: 28102941
[TBL] [Abstract][Full Text] [Related]
40. Ethiopian Plasmodium vivax hypnozoites formation dynamics and their susceptibility to reference antimalarial drugs.
Dembele L; Diakite O; Sogore F; Kedir S; Tandina F; Maiga M; Abate A; Golassa L; Djimde AA
BMC Infect Dis; 2023 Jun; 23(1):405. PubMed ID: 37312065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
